Tin tức & Cập nhật
Lọc theo Chuyên ngành:
SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) consistently reduced the risk of serious hyperkalaemia (serum potassium [K+] ≥6.0 mmol/L) without increasing the risk of hypokalaemia (serum K+ ≤3.5 mmol/L) in individuals with type 2 diabetes (T2D) at high cardiovascular (CV) risk, or in those with chronic kidney disease (CKD), a meta-analysis has shown.
SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients
23 Jun 2022HF risk: Time to rethink alcohol limits?
A moderate to high intake of alcohol appears to increase the risk of heart failure (HF) progression in individuals with pre-HF, according to a study presented at Heart Failure 2022.
HF risk: Time to rethink alcohol limits?
22 Jun 2022Estimated pulse wave velocity, socioeconomic status predict stroke risk in men
Estimated pulse wave velocity (ePWV) and socioeconomic status (SES) independently contribute to a higher risk of stroke in men, and the relationship between elevated ePWV and increased stroke risk remains whether an individual has high or low SES, according to a study.